Real-world Health Outcomes in Canadian Patients Using Semaglutide

NCT04175665 · clinicaltrials.gov ↗

COMPLETED

Status

1133

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Semaglutide

Sponsor

LMC Diabetes & Endocrinology Ltd.